期刊文献+

肾癌淋巴结切除术的进展 被引量:1

Progress of Lymph-Node Dissection in Renal Cell Carcinoma
下载PDF
导出
摘要 本文对肾癌治疗中淋巴结切除的问题作了回顾性总结,当前,在肾癌术中作出行淋巴结切除术的决定仍是复杂的。尽管如此,对那些有淋巴结转移高风险或者已有明确淋巴结转移,但没有远处转移的患者来说,淋巴结切除术仍有可能起到根治的作用。我们也探讨了腹腔镜肾癌根治术和保留肾单位肾癌切除术中淋巴结切除术的原则,一般情况下,不采用典型区域淋巴结切除术。 In this paper we review the progress of lymph-node dissection in Renal Cell Carcinoma (RCC). Decision making regarding lymph-node diaeetion (LRN) at the time of renal cancer resection is complex. There remains a role for LRN in individuals with high risk of lymph node metastasis or known LRN in whom few other options exist for aggressive, potentially curative therapy. We also discuss how to do with the development of laparoscopic and NSS. In common, formal lymphadenectomy during LRN is not routine.
出处 《中山大学研究生学刊(自然科学与医学版)》 2005年第4期29-35,共7页 Journal of the Graduates Sun YAT-SEN University(Natural Sciences.Medicine)
关键词 肾肿瘤 淋巴结切除术 肾癌根治术 Renal cell carcinoma lymph-node diaection Radical nephrectomy
  • 相关文献

参考文献1

二级参考文献18

  • 1Potter CPS,Harris AL.Diagnostic,prognostic and therapeutic implications on carbonic anhydrases in cancer.Bri J Cancer,2003,89(1):2-7.
  • 2Opavsky R,Pastorekova S,Zeinik V,et al.Gene,a novel member of the carbinic angydase familu:structure and exon to protein domain relationships.Genomics,1996,33:480-487.
  • 3Grabmaier K,Vissers JL,De Weijert MC,et al.Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250.Int J Cancer,2000,85(6):865-70.
  • 4Cho M,Uemura H,Kim SC,et al.Hypomethylation of the MN/CA9 promoter proximal region(SP) and upregulated MN/CA9 expression in human renal cell carcinoma.Br J Cancer,2001,85:563-567.
  • 5Vissers JL,De Vries IJ,Engelen LP,et al.Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.Int J Cancer,2002,100(4):441-4.
  • 6Weijtens ME,Hart EH,Bolhuis RL.Functional balance between T cell chimeric receptor density and tumor associated antigen density:CTL mediated cytolysis and lymphokine production.Gene Ther,2000,7(1):35-42.
  • 7Grabmaier K,de Weijert M,Uemura H,et al.Renal cell carcinoma-associated G250 methylation and expression:in vivo and in vitro studies.Urology,2002,60(2):357-62.
  • 8Brouwers AH,Frielink C,Oosterwijk E,et al.Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX,a potential target for(radio) immunotherapy of renal cell carcinoma.Cancer Biother Radiopharm,2003,18(4):539-47.
  • 9Kennett RH.Technology evaluation:WX-G250,Wilex/Ludwig Institute for Cancer Research.Curr Opin Mol Ther,2003,5(1):70-5.
  • 10Steffens MG,Boerman OC,Oosterwijk-Wakka JC,et al.Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.J Clin Oncol,1997,15(4):1529-37.

共引文献2

同被引文献28

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部